Willy Roth
- Internal Medicine top 0.5%
-
- Atrial Fibrillation Management and Outcomes 4
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 4
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals 5
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Pharmacological Effects and Toxicity Studies 5
-
- Analytical Chemistry and Chromatography 4
-
- Drug Transport and Resistance Mechanisms 4
-
- Neuropeptides and Animal Physiology 4
- Co-authors
- Joachim StangierKarin RathgenHildegard StähleDietmar GanßerThomas EbnerStefan BlechEva Ludwig-SchwellingerK Beschke
- Journals
- The Journal of Clinical Pharmacology (3 papers)Drug Metabolism and Disposition (3 papers)Journal of Pharmacy and Pharmacology (2 papers)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Willy Roth
23 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Internal Medicine 870
- Cardiology and Cardiovascular Medicine 1.4k
- Pharmacology 286
- Analytical Chemistry 153
- Hematology 172
Countries citing papers authored by Willy Roth
This map shows the geographic impact of Willy Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willy Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willy Roth more than expected).
Fields of papers citing papers by Willy Roth
This network shows the impact of papers produced by Willy Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willy Roth. The network helps show where Willy Roth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Willy Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 46 | |
| 2 | 2011 | 52 | |
| 3 | 2009 | 72 | |
| 4 | 2009 | 81 | |
| 5 | 2008 | 142 | |
| 6 | 2008 | 60 | |
| 7 | 2008 | 10 | |
| 8 | The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsbreakdown → | 2007 | 693 |
| 9 | The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humansbreakdown → | 2007 | 549 |
| 10 | 2006 | 144 | |
| 11 | 2006 | 16 | |
| 12 | 2006 | 13 | |
| 13 | 2004 | 6 | |
| 14 | 2002 | 16 | |
| 15 | 2000 | 46 | |
| 16 | 1991 | 16 | |
| 17 | 1989 | 32 | |
| 18 | 1986 | 66 | |
| 19 | 1983 | 31 | |
| 20 | 1983 | 11 |
About Willy Roth
Willy Roth is a scholar working on Pharmacology, Analytical Chemistry, Cardiology and Cardiovascular Medicine, Toxicology and Hematology, having authored 23 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Analytical Chemistry and Chromatography (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Neuropeptides and Animal Physiology (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Internal Medicine (870 citations), Cardiology and Cardiovascular Medicine (1.4k citations), Pharmacology (286 citations), Analytical Chemistry (153 citations) and Hematology (172 citations). Willy Roth has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dietmar Ganßer, Thomas Ebner, Stefan Blech, Eva Ludwig-Schwellinger, K Beschke, F W Koss and R Jauch. Their work appears in journals such as The Journal of Clinical Pharmacology, Drug Metabolism and Disposition, Journal of Pharmacy and Pharmacology, European Journal of Pharmaceutical Sciences and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.